← Eichor
Study identifier: NCT04457895 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.

Condition: Breast Cancer  ·  Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle

PhaseNA
Planned participants108
Who can joinFemale, 18 Years to 99 Years
Healthy volunteersNo

About this study

As much as 50% of patients treated with hormonotherapy (HT) for breast cancer (BC) suffer from osteoarticular pain during treatment. Secondary effects have become a real issue because of their consequences on the patients' quality of life, but also on treatment efficacy and survival when they induce dose reduction or premature withdrawal of treatment. Additional medicines (acupuncture, hypnosis, yoga) have become more and more popular these last years. 48 to 80% of patients with BC eventually choose them. A review comparing efficacy of various therapies to decrease osteoarticular pain concludes to a highest efficacy of anti-inflammatory treatments, paracetamol and yoga. It thus appears innovative to complete this care with a patient educational project (PEP) in postural yoga instructed by a trained physical therapist, which will enable patients to practice yoga postures at home by themselves. The investigators conducted a pilot study "SKYPE" with 24 algic patients treated with HT after BC, whose results are very promising. The investigators now propose in the continuity of the pilot study a multicenter randomized controlled study comparing the efficacy of SKYPE care on pain reduction, an educative care combining physical therapy and yoga, to a control group in patients treated with HT for a BC with osteoarticular and/or musculoskeletal pain. Furthermore, in order to examine whether yoga interventions may influence inflammation through their effects on the level of a wide…

This description comes directly from the study's public registry record.

Talk to the study team

Moussion Aurore  ·  +33467612446  ·  aurore.moussion@icm.unicancer.fr

Emmanuelle Texier  ·  04 67 61 31 02  ·  DRCI-icm105@icm.unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (7)

CH LibourneLibourne, Aquitaine, FranceRecruiting
Icm Val D'AurelleMontpellier, Herault, FranceRecruiting
CHU NîmesNîmes, Herault, FranceRecruiting
Insitut de Cancérologie de LorraineVandœuvre-lès-Nancy, Meurthe-et-Moselle,, FranceRecruiting
Institut BergoniéBordeaux, New Aquitaine, FranceRecruiting
Institut du sein BasqueTosse, New Aquitaine, FranceRecruiting
Institut de Cancérologie de l'OuestAngers, Pays de la Loire Region, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04457895